Altria Group Stock: Is MO Underperforming the Consumer Defensive Sector?

Richmond, Virginia-based Altria Group, Inc. (MO) manufactures and sells smokable and oral tobacco products in the United States. The company is valued at $119.5 billion and offers cigarettes primarily under the Marlboro brand, large cigars and pipe tobacco under the Black & Mild brand, moist smokeless tobacco and oral tobacco products, and more. 

Companies with a market cap of $10 billion or more are typically called “large-cap stocks.” MO fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the tobacco industry.   

However, the tobacco giant currently trades 9.7% below its 52-week high of $77.06 recorded on July 28. MO has grown marginally over the past three months, underperforming the State Street Consumer Staples Select Sector SPDR ETF’s (XLP) 4.5% rise during the same time frame.     

In the longer term, MO has delivered a similar performance. The stock has grown 3.6% over the past 52 weeks, underperforming the 6.1% rise of XLP over the same period. MO has been trading above its 200-day moving average since August and below its 50-day moving average since the end of July. 

On July 30, MO stock declined 9.3% following the release of its mixed Q2 2026 earnings. The company’s revenue for the quarter amounted to $6.1 billion, which met the Street’s estimates. However, its adjusted EPS came in at $1.48, falling short of Wall Street’s forecasts.  Additionally, Altria narrowed its full-year 2026 adjusted diluted EPS guidance to $5.61 to $5.72.

When stacked against its rival, Philip Morris International Inc. (PM) has grown 12.2% over the past year, outperforming MO stock.       

Wall Street has a moderately bullish view of the stock currently. Among the 15 analysts tracking MO, the overall consensus stands at a “Moderate Buy.” Its mean price target of $69.58 suggests a marginal upside potential from current price levels.   smokable

On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.